Is Mereo BioPharma Group plc (MREO) a Buy, Sell, or Hold?
Mereo BioPharma Group plc
NASDAQ:MREO
$0.3279 USD
$0.01 (4.43%)
- Volume
- 864.89K
- Average Volume
- 3.4M
- Market Capitalization
- $52.34M
- P/E Ratio
- -1.46
- Dividend Yield
- 0.00%
- Price Target
- $2.50
- Year High
- $2.37
- Year Low
- $0.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.48
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
77
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
42
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.77M
MREO Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
MREO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Jacquet Pierre | director | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| Jacquet Pierre | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| Yoskowitz Marc J | director | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| Yoskowitz Marc J | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| Shames Daniel | director | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| Shames Daniel | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| Ekblom Anders | director | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| Ekblom Anders | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| Bender Jeremy | director | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| Bender Jeremy | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| PAKIANATHAN DEEPIKA | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| Jenkins Annalisa | director | 2026-02-26 | A-Award | 0 | 2026-02-27 |
| Jenkins Annalisa | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| WYZGA MICHAEL S | director | 2026-02-26 | A-Award | 0.39 | 2026-02-27 |
| Lewicki John A. | officer: Chief Scientific Officer | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Lewicki John A. | officer: Chief Scientific Officer | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Lewicki John A. | officer: Chief Scientific Officer | 2026-02-01 | A-Award | 1 | 2026-02-02 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2026-02-01 | A-Award | 1 | 2026-02-02 |
| Sermon Charles | officer: General Counsel | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Sermon Charles | officer: General Counsel | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Sermon Charles | officer: General Counsel | 2026-02-01 | A-Award | 1 | 2026-02-02 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2026-02-01 | A-Award | 1 | 2026-02-02 |
| Fox Christine Ann | officer: Chief Financial Officer | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Fox Christine Ann | officer: Chief Financial Officer | 2026-02-01 | A-Award | 0.44 | 2026-02-02 |
| Fox Christine Ann | officer: Chief Financial Officer | 2026-02-01 | A-Award | 1 | 2026-02-02 |
| Yoskowitz Marc J | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| Yoskowitz Marc J | director | 2025-02-05 | A-Award | 0 | 2025-02-06 |
| PAKIANATHAN DEEPIKA | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| Bender Jeremy | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| Bender Jeremy | director | 2025-02-05 | A-Award | 0 | 2025-02-06 |
| Ekblom Anders | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| Ekblom Anders | director | 2025-02-05 | A-Award | 0 | 2025-02-06 |
| WYZGA MICHAEL S | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| Shames Daniel | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| WYZGA MICHAEL S | director | 2025-02-05 | A-Award | 0 | 2025-02-06 |
| Shames Daniel | director | 2025-02-05 | A-Award | 0 | 2025-02-06 |
| Jenkins Annalisa | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| Jenkins Annalisa | director | 2025-02-05 | A-Award | 0 | 2025-02-06 |
| Jacquet Pierre | director | 2025-02-05 | A-Award | 3.16 | 2025-02-06 |
| Jacquet Pierre | director | 2025-02-05 | A-Award | 0 | 2025-02-06 |
| Lewicki John A. | officer: Chief Scientific Officer | 2025-01-25 | A-Award | 2.91 | 2025-01-28 |
| Fox Christine Ann | officer: Chief Financial Officer | 2025-01-25 | A-Award | 2.91 | 2025-01-28 |
| Sermon Charles | officer: General Counsel | 2025-01-25 | A-Award | 2.91 | 2025-01-28 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2025-01-25 | A-Award | 2.91 | 2025-01-28 |
| Scots-Knight Denise | officer: Chief Executive Officer | 2025-01-25 | A-Award | 2.91 | 2025-01-28 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2024-09-12 | S-Sale | 4.4727 | 2024-09-16 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2024-09-13 | S-Sale | 4.221 | 2024-09-16 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-09-12 | S-Sale | 4.4727 | 2024-09-16 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-09-13 | S-Sale | 4.221 | 2024-09-16 |
| Sermon Charles | officer: General Counsel | 2024-09-12 | S-Sale | 4.4727 | 2024-09-16 |
| Sermon Charles | officer: General Counsel | 2024-09-13 | S-Sale | 4.221 | 2024-09-16 |
| Fox Christine Ann | officer: Chief Financial Officer | 2024-09-12 | S-Sale | 4.4727 | 2024-09-16 |
| Fox Christine Ann | officer: Chief Financial Officer | 2024-09-13 | S-Sale | 4.221 | 2024-09-16 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-12 | S-Sale | 4.4727 | 2024-09-16 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-12 | S-Sale | 4.4727 | 2024-09-16 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-13 | S-Sale | 4.221 | 2024-09-16 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-13 | S-Sale | 4.221 | 2024-09-16 |
| Sermon Charles | officer: General Counsel | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Sermon Charles | officer: General Counsel | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Fox Christine Ann | officer: Chief Financial Officer | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Fox Christine Ann | officer: Chief Financial Officer | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-11 | M-Exempt | 1.01 | 2024-09-13 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-11 | M-Exempt | 1.4 | 2024-09-13 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-11 | M-Exempt | 1.01 | 2024-09-13 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-11 | M-Exempt | 0 | 2024-09-13 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-09-11 | M-Exempt | 1.4 | 2024-09-13 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 3.87 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 0.94 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 1.31 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 3.87 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 2.72 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 1.84 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 3 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 1.84 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 1.31 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 2.72 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 0.94 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | M-Exempt | 3 | 2024-08-23 |
| PAKIANATHAN DEEPIKA | director | 2024-08-22 | S-Sale | 4.4298 | 2024-08-23 |
| Sermon Charles | officer: General Counsel | 2024-06-25 | S-Sale | 3.6939 | 2024-06-27 |
| Sermon Charles | officer: General Counsel | 2024-06-26 | S-Sale | 3.3932 | 2024-06-27 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-06-25 | S-Sale | 3.6939 | 2024-06-27 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-06-26 | S-Sale | 3.3932 | 2024-06-27 |
| Fox Christine Ann | officer: Chief Financial Officer | 2024-06-25 | S-Sale | 3.6939 | 2024-06-27 |
| Fox Christine Ann | officer: Chief Financial Officer | 2024-06-26 | S-Sale | 3.3932 | 2024-06-27 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2024-06-25 | S-Sale | 3.6939 | 2024-06-27 |
| Scots-Knight Denise | director, officer: Chief Executive Officer | 2024-06-26 | S-Sale | 3.3932 | 2024-06-27 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-06-25 | S-Sale | 3.6939 | 2024-06-27 |
| Hughes-Wilson Alexandra | officer: See Remarks | 2024-06-26 | S-Sale | 3.3932 | 2024-06-27 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-06-21 | M-Exempt | 0 | 2024-06-25 |
| Lewicki John A. | officer: Chief Scientific Officer | 2024-06-21 | M-Exempt | 0 | 2024-06-25 |